Mayo Clinic names Matthew R. Callstrom as next president and CEO

Mayo Clinic has elected Matthew R. Callstrom, M.D., Ph.D., as its next president and CEO, succeeding Gianrico Farrugia, M.D. Farrugia will remain in the role through December 31, 2026, to support the leadership transition.
- Matthew R. Callstrom will become Mayo Clinic president and CEO.
- Gianrico Farrugia will remain in the role through December 31, 2026.
- Callstrom joined Mayo Clinic in 2002 and leads its Strategy and AI Program.
- His work includes image-guided cancer treatment and more than 200 publications and patents.
- Farrugia has led Mayo Clinic since 2019.
Callstrom brings clinical, research and AI leadership
Callstrom joined Mayo Clinic in 2002 and has held leadership positions across clinical practice, research, strategy, artificial intelligence and innovation. He is a member of Mayo Clinic's Board of Governors and Board of Trustees, and serves as medical director for Mayo Clinic Strategy and the AI Program.
He previously served as interim chief strategy officer and chair of the Department of Radiology at Mayo Clinic in Rochester. In those roles, he helped shape the organization's strategy and advance what Mayo Clinic describes as the responsible integration of AI into medicine. The work has included efforts to accelerate the discovery of new cures, detect disease earlier and give clinicians new capabilities for treating patients with serious and complex conditions.
A physician-scientist focused on image-guided cancer care
Callstrom is a physician-scientist and body interventional radiologist whose work has focused on patient care, science and innovation. Mayo Clinic says he is internationally recognized for advancing image-guided cancer treatment, including technologies designed to identify and treat cancer more precisely.
He has led and collaborated on numerous clinical trials, and his work has produced more than 200 publications and patents. He has also been recognized as a Mayo Clinic Distinguished Clinician and served as president of the Society of Interventional Oncology.
A Minnesota native, Callstrom earned degrees in chemical engineering and chemistry from the University of Minnesota Twin Cities. He completed a postdoctoral fellowship at Harvard University, earned his medical degree from Mayo Clinic Alix School of Medicine, and completed residency and fellowship training at Mayo Clinic in Rochester.
Leadership change follows Mayo Clinic transformation
Farrugia has served as Mayo Clinic's president and CEO since 2019. During his tenure, Mayo Clinic launched and advanced Bold. Forward., a strategy centered on accelerating the discovery, translation and delivery of more cures for chronic and acute diseases.
The strategy also includes connecting people with data to create new knowledge and deliver scalable end-to-end solutions. Mayo Clinic says it has also created Mayo Clinic Platform, its first comprehensive, scalable, AI-enabled care transformation platform.
Richard K. Davis, chair of the Mayo Clinic Board of Trustees, said Callstrom's experience across patient care, research, strategy and innovation positions him to lead the organization. The appointment places a leader with long experience at Mayo Clinic and responsibility for its AI program at the head of the nonprofit healthcare organization.
Callstrom said he intends to build on Mayo Clinic's clinical expertise, science and innovation, including by translating discovery and emerging technologies into better care and extending Mayo Clinic's impact to more patients, wherever they are.


